1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Brazil Pharmaceuticals and Healthcare Report Q2 2016

Brazil Pharmaceuticals and Healthcare Report Q2 2016

  • January 2016
  • -
  • Business Monitor International
  • -
  • 109 pages

BMI View: Brazil will continue to be the most important market for multinational pharmaceuticalcompanies in Latin America, despite growing financial tensions, increasing pricing pressure and genericcompetition. Headline Expenditure ProjectionsPharmaceuticals: BRL65.8bn (USD19.8bn) in 2015 to BRL69.8bn (USD18.4bn) in 2016; +6.1% in localcurrency terms and -7.0% in US dollar terms. Forecast in has stayed the same as in Q116.Healthcare: BRL509.9bn (USD216.7bn) in 2015 to BRL601.1bn (USD158.2bn) in 2016; +8.3% in localcurrency terms and -5.0% in US dollar terms. Forecast in local currency has been revised downward fromQ116.

Table Of Contents

Brazil Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Brazil 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2014-2020) 30
Industry Risk/Reward Index 31
Americas Risk/Reward Index 31
Brazil Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 40
Pricing Regime 43
Reimbursement Regime 44
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Brazil 2010-2015) 49
Table: Healthcare Personnel (Brazil 2010-2015) 49
Table: Healthcare Activity (Brazil 2010-2015) 50
Research and Development 50
Biotechnology 52
Clinical Trials 53
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013 57
Table: Multinational Pharmaceutical Company Activity 58
Generic Drugmakers 58
Pharmaceutical Distribution 61
Pharmaceutical Retail Sector 63
Company Profile 65
Ache/Biosintetica 65
Cristália 69
EMS Sigma 72
Eurofarma 75
GlaxoSmithKline 77
Table: GlaxoSMITHKLINE'S Strong Collaborative Efforts In Public-Private Partnerships (Ppps) In Brazil 79
Medley 81
Merck and Co 83
Novartis 86
Pfizer 89
Roche 92
Sanofi 95
Demographic Forecast 98
Table: Population Headline Indicators (Brazil 1990-2025) 99
Table: Key Population Ratios (Brazil 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (Brazil 1990-2025) 100
Table: Population By Age Group (Brazil 1990-2025) 100
Table: Population By Age Group % (Brazil 1990-2025) 101
Glossary 103
Methodology 105
Pharmaceutical Expenditure Forecast Model 105
Healthcare Expenditure Forecast Model 105
Notes On Methodology 106
Risk/Reward Index Methodology 107
Index Overview 108
Table: Pharmaceutical Risk/Reward Index Indicators 108
Indicator Weightings 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.